Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. - Subbiah, Vivek; Hu, Mimi I.; Mansfield, Aaron S.; Taylor, Matthew H.; Schuler, Martin; Zhu, Viola W.; Hadoux, Julien; Curigliano, Giuseppe; Wirth, Lori; Gainor, Justin F.; Alonso, Guzman; Adkins, Douglas; et al. (Thyroid, 2024)